2024 National Veteran Suicide Prevention Annual Report- Part 1 of 2: In-Depth Reviews

Abstract: This 2024 National Veteran Suicide Prevention Annual Report presents the most current and comprehensive data on suicide among U.S. Veterans and non-Veteran adults, from 2001 through 2022. This report delves into the critical public health issue of Veteran suicide, providing information regarding Veteran suicide in relation to factors such as firearm involvement, military sexual trauma (MST), substance use disorders, transitions to civilian life, cancer, nicotine use, COVID-19, and homelessness, and across demographic and contextual factors, such as age, sex, gender identity, race, and ethnicity. Building upon previous reports, this edition introduces new content that explores suicide among Veterans receiving care through the Veterans Health Administration (VHA) or VA-funded community care, as well as suicide rates following separations from active military service. The report documents year-to-year variations and long-term patterns as well. Additionally, it shares insights from key contributors and highlights initiatives and resources within the broad scope of the Department of Veterans Affairs (VA) suicide prevention activities.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P